sleep medicine

Jazz Highlights New Xywav Data Across Narcolepsy and Idiopathic Hypersomnia

DUBLIN, Ireland, June 4, 2026 Jazz Pharmaceuticals has announced the presentation of an extensive portfolio of new clinical and...

By cGxPwire Editor
June 6, 2026

M&A

Resmed Completes Noctrix Health Acquisition to Expand Sleep Care

SAN DIEGO, June 1, 2026 Resmed has completed its acquisition of Noctrix Health, significantly expanding its clinical sleep health...

By cGxPwire Editor
June 3, 2026

.Clinical

Apnimed Highlights Phase 3 AD109 OSA Data at ATS 2026

CAMBRIDGE, Mass., May 11, 2026 Apnimed announced multiple scientific presentations, including three oral presentations and a late-breaking poster, at...

By cGxPwire Editor
May 12, 2026

M&A

Alkermes Expands Sleep Portfolio With Avadel Buy

DUBLIN, Feb. 12, 2026 — Alkermes plc has completed its acquisition of Avadel Pharmaceuticals plc, accelerating its strategic entry...

By cGxPwire Editor
February 13, 2026

MedTech

Nyxoah Begins U.S. Launch of Genio System for Sleep Apnea

MONT-SAINT-GUIBERT, Belgium, Oct. 6, 2025 — Nyxoah SA announced that the first U.S. commercial patients have been implanted with...

By cGxPwire Editor
October 6, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Jazz Highlights New Xywav Data Across Narcolepsy and Idiopathic Hypersomnia

Resmed Completes Noctrix Health Acquisition to Expand Sleep Care

Apnimed Highlights Phase 3 AD109 OSA Data at ATS 2026

Alkermes Expands Sleep Portfolio With Avadel Buy

Nyxoah Begins U.S. Launch of Genio System for Sleep Apnea